Download Free Sample Report

Noninvasive Prenatal Diagnostics Market, Global Outlook and Forecast 2023-2030

Noninvasive Prenatal Diagnostics Market, Global Outlook and Forecast 2023-2030

  • Published on : 26 September 2023
  • Pages :60
  • Report Code:SMR-7818355

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Noninvasive Prenatal Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
 

Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
This report aims to provide a comprehensive presentation of the global market for Noninvasive Prenatal Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Noninvasive Prenatal Diagnostics. This report contains market size and forecasts of Noninvasive Prenatal Diagnostics in global, including the following market information:

  • Global Noninvasive Prenatal Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
  • Global top five companies in 2022 (%)

North America has the largest share of the noninvasive prenatal diagnostics market, with Asia Pacific and the Middle East achieving the fastest growth.
We surveyed the Noninvasive Prenatal Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Noninvasive Prenatal Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Type, 2022 (%)

  • Services
  • Instrument

Global Noninvasive Prenatal Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Application, 2022 (%)

  • Hospital
  • Personal
  • Other

Global Noninvasive Prenatal Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Noninvasive Prenatal Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Noninvasive Prenatal Diagnostics revenues share in global market, 2022 (%)

Key players include:

  • Natera
  • Illumina
  • BGI Diagnosis
  • Ariosa Diagnostics
  • Quest Diagnostics
  • Premaitha Health
  • NIPD Genetics
  • Labcorp
  • Ravgen
  • LifeCodexx
  • TrovaGene
  • Quest Diagnostics
  • Berry Genomics

Outline of Major Chapters:
Chapter 1: Introduces the definition of Noninvasive Prenatal Diagnostics, market overview.
Chapter 2: Global Noninvasive Prenatal Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Noninvasive Prenatal Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Noninvasive Prenatal Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.